Clinical Trials Browser

Completed × onvansertib × Other hematologic neoplasm × Clear all

NCT03303339 2023-02-27

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Phase 1/2 Completed

72 enrolled 31 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute